ImageneBio (IMA) EBT Margin (2020 - 2025)

ImageneBio has disclosed EBT Margin across 6 years of filings, most recently posting 759.62% for Q1 2025.

• EBT Margin for Q1 2025 came in at 759.62%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2025 was 655.18% (changed N/A YoY), and the FY2023 annual result was 745.94%, down 30565.0% from the prior year.
• EBT Margin came in at 759.62% for Q1 2025 at ImageneBio, down from 90.94% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 13.83% in Q4 2021 to a low of 5376.44% in Q2 2022.
• The 5-year median for EBT Margin is 372.4% (2021), against an average of 988.0%.
• Across the five-year window, EBT Margin soared 4009537 bps in 2021 and sank 501913 bps in 2022, its largest moves.
• ImageneBio's EBT Margin stood at 13.83% in 2021, then plunged by 1970 bps to 258.66% in 2022, then tumbled by 1053 bps to 2981.94% in 2023, then jumped by 97 bps to 90.94% in 2024, then sank by 735 bps to 759.62% in 2025.
• The last three EBT Margin figures came in at 759.62% (Q1 2025), 90.94% (Q3 2024), and 2981.94% (Q4 2023), per Business Quant data.